v3.26.1
Unaudited Condensed Statements of Changes in Shareholders’ Equity (Deficit) - USD ($)
Ordinary Shares
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Total
Balance at Dec. 31, 2024 $ 150 $ 24,850 $ (77,094) $ (52,094)
Balance (in Shares) at Dec. 31, 2024 [1] 1,500,000      
Accretion of carrying value to redemption value (3,262,254) (3,262,254)
Issuance of Private Placement Units net of issuance cost of $9,453 $ 23 2,333,424 2,333,447
Issuance of Private Placement Units net of issuance cost of $9,453 (in Shares) [1] 234,290      
Issuance of Public Rights net of issuance costs of $39,560 1,280,440 1,280,440
Issuance of Representative Shares $ 21 360,979 361,000
Issuance of Representative Shares (in Shares) [1] 210,000      
Issuance of independent director shares 61,478 61,478
Net income 149,799 149,799
Balance at Mar. 31, 2025 $ 194 798,917 72,705 871,816
Balance (in Shares) at Mar. 31, 2025 [1] 1,944,290      
Balance at Dec. 31, 2025 $ 194 179,044 179,238
Balance (in Shares) at Dec. 31, 2025 1,944,290      
Accretion of carrying value to redemption value (287,400) (287,400)
Extension fees deposited into trust account (150,000) (150,000)
Net income 61,472 61,472
Balance at Mar. 31, 2026 $ 194 $ (196,884) $ (196,690)
Balance (in Shares) at Mar. 31, 2026 1,944,290      
[1] Ordinary shares have been retroactively restated to reflect the Sponsor’s forfeiture of 225,000 Founder Shares on March 10, 2025 for no consideration as the underwriters of the IPO did not exercise the over-allotment option.